We found no RCTs or controlled trials of other oral agents in cutaneous lupus. There are many case reports describing success in individuals or small numbers of patients. Favourable case reports describe cefuroxime,116 cyclophosphamide,117 ciclosporin A,118,119 cytarabine,120 interferon alfa (parenteral and intralesional),121,122 intravenous immunoglobulin,123,124 chimeric monoclonal antibodies,125 mycophenolate mofetil,126 and pulses of methylprednisolone.127 An open trial of sulfasalazine in 13 patients with cutaneous lupus demonstrated an excellent or good response in eight,128 and there is a favourable case report on the treatment of DLE with sulfasalazine.129
De Pitá et al. could not reproduce the favourable response to immunoglobulins - of their seven patients with SCLE none responded to this therapy.130
Was this article helpful?
Do You Suffer From the Itching and Scaling of Psoriasis? Or the Chronic Agony of Psoriatic Arthritis? If so you are not ALONE! A whopping three percent of the world’s populations suffer from either condition! An incredible 56 million working hours are lost every year by psoriasis sufferers according to the National Psoriasis Foundation.